BioPharm International-03-01-2016

BioPharm International

Generic-Drug Production and Oversight Challenge FDA and Manufacturers

March 01, 2016

Regulatory Beat

29

3

Policy makers debate strategies for promoting access to less costly medicines.

Keynote Series Addresses Crucial Industry Issues

March 01, 2016

From the Editor

29

3

Thought leaders tackle drug shortages and biomanufacturing challenges.

Biopharma Outsourcing Market Expands

March 01, 2016

Perspectives on Outsourcing

29

3

The biopharmaceutical outsourcing market starts 2016 with company expansions, acquisitions, and new offerings.

Creating Robust CAPA Systems

March 01, 2016

Ask the Expert

29

3

Susan Schniepp, distinguished fellow, and Andrew Harrison, chief regulatory affairs officer and general counsel, both of Regulatory Compliance Associates, discuss how to create a robust CAPA system and how to identify root cause.

Microbial Vectors for the Production of mAbs

March 01, 2016

Features

29

3

Microbial models offer some exciting production alternatives.

Miniature Bioreactors for Improved Process Understanding

March 01, 2016

Features

29

3

Miniature bioreactors add value by reducing validation efforts.

BioPharm International, March 2016 Issue (PDF)

March 01, 2016

Issue PDF

29

3

Click the title above to open the BioPharm International March 2016 issue in an interactive PDF format.